HER2 insertion YVMA mutant lung cancer: long natural history and response to afatinib

Human epidermal growth factor 2 (HER2, ERBB2) mutations in lung cancers are oncogenic drivers that respond to HER2 targeted therapies. Little is known about the sensitivity of subtypes of HER2 mutant lung cancers to targeted agents. We present a patient with HER2 mutant lung cancer with a 12 base pa...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Lung Cancer
Huvudupphovsmän: Li, Bob T., Lee, Adrian, O'Toole, Sandra, Cooper, Wendy, Yu, Bing, Chaft, Jamie E., Arcila, Maria E., Kris, Mark G., Pavlakis, Nick
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4724317/
https://ncbi.nlm.nih.gov/pubmed/26559459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2015.10.025
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk